Patents by Inventor Steven David Gardner
Steven David Gardner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240390609Abstract: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.Type: ApplicationFiled: June 12, 2024Publication date: November 28, 2024Applicant: Norton (Waterford) LimitedInventors: Enrique Calderon Oliveras, Daniel Buck, Erica Jamie Kantor, Ross William Weir, James Roche, Steven David Gardner, Robert Owen Kivlin
-
Publication number: 20210220579Abstract: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.Type: ApplicationFiled: April 6, 2021Publication date: July 22, 2021Applicant: Norton (Waterford) LimitedInventors: Enrique Calderon Oliveras, Daniel Buck, Erica Jamie Kantor, Ross William Weir, James Roche, Steven David Gardner, Robert Owen Kivlin
-
Patent number: 11000653Abstract: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.Type: GrantFiled: September 14, 2017Date of Patent: May 11, 2021Assignee: Norton (Waterford) LimitedInventors: Enrique Calderon Oliveras, Daniel Buck, Erica Jamie Kantor, Ross William Weir, James Roche, Steven David Gardner, Robert Owen Kivlin
-
Patent number: 10839669Abstract: In some embodiments, a method includes producing, from an adapter, a first wireless signal characterized by a first communication mode with a computing device when a portion of at least one of a medicament delivery device or a simulated medicament delivery is disposed within the adapter. An indication is received when the portion of the medicament delivery device or the simulated medicament delivery device is removed from the adapter. A second wireless signal characterized by a second communication mode with the computing device is produced in response to the indication. The second communication mode is different from the first communication mode. The second communication mode can be, for example, a hold mode, a sniff mode or a park mode.Type: GrantFiled: January 31, 2018Date of Patent: November 17, 2020Assignee: kaleo, Inc.Inventors: Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers, Vaishali Vilas Kamat, Steven David Gardner, Robert George Milner
-
Publication number: 20180151053Abstract: In some embodiments, a method includes producing, from an adapter, a first wireless signal characterized by a first communication mode with a computing device when a portion of at least one of a medicament delivery device or a simulated medicament delivery is disposed within the adapter. An indication is received when the portion of the medicament delivery device or the simulated medicament delivery device is removed from the adapter. A second wireless signal characterized by a second communication mode with the computing device is produced in response to the indication. The second communication mode is different from the first communication mode. The second communication mode can be, for example, a hold mode, a sniff mode or a park mode.Type: ApplicationFiled: January 31, 2018Publication date: May 31, 2018Applicant: kaleo, Inc.Inventors: Eric S. EDWARDS, Evan T. EDWARDS, Mark J. LICATA, Paul F. MEYERS, Vaishali Vilas KAMAT, Steven David GARDNER, Robert George MILNER
-
Publication number: 20180140788Abstract: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.Type: ApplicationFiled: September 14, 2017Publication date: May 24, 2018Applicant: Norton (Waterford) LimitedInventors: Enrique Calderon Oliveras, Daniel Buck, Erica Jamie Kantor, Ross William Weir, James Roche, Steven David Gardner, Robert Owen Kivlin
-
Patent number: 9911308Abstract: In some embodiments, a method includes producing, from an adapter, a first wireless signal characterized by a first communication mode with a computing device when a portion of at least one of a medicament delivery device or a simulated medicament delivery is disposed within the adapter. An indication is received when the portion of the medicament delivery device or the simulated medicament delivery device is removed from the adapter. A second wireless signal characterized by a second communication mode with the computing device is produced in response to the indication. The second communication mode is different from the first communication mode. The second communication mode can be, for example, a hold mode, a sniff mode or a park mode.Type: GrantFiled: December 27, 2013Date of Patent: March 6, 2018Assignee: kaleo, Inc.Inventors: Eric S. Edwards, Evan T. Edwards, Mark J. Licata, Paul F. Meyers, Vaishali Vilas Kamat, Steven David Gardner, Robert George Milner
-
Publication number: 20170072160Abstract: In various arrangements, a nebulizer element of a nebulizer may be energized with a drive signal. A phase offset of the drive signal may be measured. A phase delta may be determined. The phase delta may indicate a difference between a target phase offset and the measured phase offset. The target phase offset may indicate a non-zero target phase difference between the voltage of the drive signal and the current of the drive signal. A frequency of the drive signal may be changed to decrease the phase delta.Type: ApplicationFiled: November 23, 2016Publication date: March 16, 2017Applicant: Nektar TherapeuticsInventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
-
Patent number: 9533118Abstract: In various arrangements, a nebulizer element of a nebulizer may be energized with a drive signal. A phase offset of the drive signal may be measured. A phase delta may be determined. The phase delta may indicate a difference between a target phase offset and the measured phase offset. The target phase offset may indicate a non-zero target phase difference between the voltage of the drive signal and the current of the drive signal. A frequency of the drive signal may be changed to decrease the phase delta.Type: GrantFiled: September 4, 2013Date of Patent: January 3, 2017Assignee: Nektar TherapeuticsInventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
-
Publication number: 20160058958Abstract: Various methods, devices, and systems are described for aerosolizing a liquid. Embodiments may include sealing the liquid within a reservoir. An output waveform signal may be generated. A nebulizer element may be vibrated to aerosolize the liquid. A negative pressure may be produced within the reservoir as the liquid is aerosolized. The output waveform signal may cause the nebulizer element to vibrate. Embodiments may involve determining a phase shift between a current of the output waveform signal and a voltage of the output waveform signal. Also, embodiments may involve adjusting a frequency of the output waveform signal at least partially based on the phase shift. Further, embodiments may involve adjusting the voltage of the output waveform signal at least partially based on the frequency of the output waveform signal.Type: ApplicationFiled: September 1, 2015Publication date: March 3, 2016Applicant: Nektar TherapeuticsInventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
-
Patent number: 9272101Abstract: Various arrangements for determining whether a liquid is in contact with a nebulizer element are disclosed. A nebulizer element may be energized with an electrical signal at a measurement frequency. An impedance of the nebulizer element may be measured, thereby obtaining a measured impedance value. The impedance value may be compared to a stored impedance value. Based on the comparison, it may be determined whether the liquid contacts the nebulizer element.Type: GrantFiled: January 19, 2011Date of Patent: March 1, 2016Assignee: NEKTAR THERAPEUTICSInventors: Benjamin Morris Gordon, Steven David Gardner, Thomas Edward Parker
-
Patent number: 9149588Abstract: Various methods, devices, and systems are described for aerosolizing a liquid. Embodiments may include sealing the liquid within a reservoir. An output waveform signal may be generated. A nebulizer element may be vibrated to aerosolize the liquid. A negative pressure may be produced within the reservoir as the liquid is aerosolized. The output waveform signal may cause the nebulizer element to vibrate. Embodiments may involve determining a phase shift between a current of the output waveform signal and a voltage of the output waveform signal. Also, embodiments may involve adjusting a frequency of the output waveform signal at least partially based on the phase shift. Further, embodiments may involve adjusting the voltage of the output waveform signal at least partially based on the frequency of the output waveform signal.Type: GrantFiled: July 19, 2010Date of Patent: October 6, 2015Assignee: NEKTAR THERAPEUTICSInventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
-
Publication number: 20140243749Abstract: In some embodiments, a method includes producing, from an adapter, a first wireless signal characterized by a first communication mode with a computing device when a portion of at least one of a medicament delivery device or a simulated medicament delivery is disposed within the adapter. An indication is received when the portion of the medicament delivery device or the simulated medicament delivery device is removed from the adapter. A second wireless signal characterized by a second communication mode with the computing device is produced in response to the indication. The second communication mode is different from the first communication mode. The second communication mode can be, for example, a hold mode, a sniff mode or a park mode.Type: ApplicationFiled: December 27, 2013Publication date: August 28, 2014Applicant: INTELLIJECT, INC.Inventors: Eric S. EDWARDS, Evan T. EDWARDS, Mark J. LICATA, Paul F. MEYERS, Vaishali KAMAT, Steven David Gardner, Robert George Milner
-
Publication number: 20140007864Abstract: In various arrangements, a nebulizer element of a nebulizer may be energized with a drive signal. A phase offset of the drive signal may be measured. A phase delta may be determined. The phase delta may indicate a difference between a target phase offset and the measured phase offset. The target phase offset may indicate a non-zero target phase difference between the voltage of the drive signal and the current of the drive signal. A frequency of the drive signal may be changed to decrease the phase delta.Type: ApplicationFiled: September 4, 2013Publication date: January 9, 2014Applicant: Nektar TherapeuticsInventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
-
Publication number: 20120291777Abstract: Various arrangements for determining whether a liquid is in contact with a nebulizer element are disclosed. A nebulizer element may be energized with an electrical signal at a measurement frequency. An impedance of the nebulizer element may be measured, thereby obtaining a measured impedance value. The impedance value may be compared to a stored impedance value. Based on the comparison, it may be determined whether the liquid contacts the nebulizer element.Type: ApplicationFiled: January 19, 2011Publication date: November 22, 2012Applicant: NEKTAR THERAPEUTICSInventors: Benjamin Morris Gordon, Steven David Gardner, Thomas Edward Parker
-
Publication number: 20120111963Abstract: Various methods, devices, and systems are described for aerosolizing a liquid. Embodiments may include sealing the liquid within a reservoir. An output waveform signal may be generated. A nebulizer element may be vibrated to aerosolize the liquid. A negative pressure may be produced within the reservoir as the liquid is aerosolized. The output waveform signal may cause the nebulizer element to vibrate. Embodiments may involve determining a phase shift between a current of the output waveform signal and a voltage of the output waveform signal. Also, embodiments may involve adjusting a frequency of the output waveform signal at least partially based on the phase shift. Further, embodiments may involve adjusting the voltage of the output waveform signal at least partially based on the frequency of the output waveform signal.Type: ApplicationFiled: July 19, 2010Publication date: May 10, 2012Applicant: Nektar TherapeuticsInventors: Benjamin Morris Gordon, Steven David Gardner, Matthew James Hayes
-
Patent number: D804437Type: GrantFiled: September 30, 2016Date of Patent: December 5, 2017Assignee: Norton (Waterford) LimitedInventors: Erica Jamie Kantor, Steven David Gardner, Ross William Weir